Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > New interview with Dr Coffey
View:
Post by Quentin30 on Nov 15, 2022 6:07pm

New interview with Dr Coffey

Comment by Hand2Hand on Nov 15, 2022 7:32pm
"Expect to start Registration in 6 to 9 months." They are definitely talking to the FDA at this moment. "Investment potential in Oncolytics can be huge. Especially since they are 2 phase iii trials ready in two different indications." Personally I can't understand why this company is still valued under 100 million.
Comment by fox7mf on Nov 15, 2022 7:58pm
Coffey states they expect to start ph3 registration in 6 to 9 months? That's probably anywhere between late April and late June. They're already knee deep in partnership/buyout talks, sped up considerably by the Goblet data. I wouldn't rule out news on this front late 2022, or Q1 2023. Whoever wins the bidding war will want to get all their ducks in a row to conduct the multiple ph3 ...more  
Comment by westcoast1000 on Nov 16, 2022 11:37am
We should all recall the quarterly conferemce call when the first half results were announced. The BD guy said very clearly and definitely that we were at that point "in discussions" with multiple bp companies in multiple indications. That would seem to be about as much as they can say without running afoul of disclosure rules.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities